Experimental eczema drug tested in healthy people – but trial halted
Knowledge-focused
Terminated
This was a very early (Phase 1) study to check the safety of an experimental drug called IPG7236, taken as a pill. The study involved 63 healthy adults aged 18 to 55. The goal was to see how the body handles the drug and if it causes side effects, before testing it in people with…
Phase: PHASE1 • Sponsor: Nanjing Immunophage Biotech Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC